Tag: SMT
SMT’s Hydra TAVR Valve demonstrates sustained safety, durability, and hemodynamic performance...
At 5 years, Hydra demonstrated high overall survival, low rates of disabling stroke, and durable valve performance with stable gradients and effective orifice area
SMT’s Supraflex Cruz shows consistent & robust clinical outcomes across key...
The collective data reinforces the proven safety, efficacy, and consistent performance of the Supraflex Cruz drug eluting stent (DES) across a broad spectrum of complex patient populations
Sahajanand Medical Technologies appoints Priyanka Cohen & Harvinder Singh to its...
Harvinder Singh has joined as an Independent Director and Priyanka Cohen joins the board as a Director
India coronary stent market set for 4% CAGR growth during 2024-2033,...
India’s coronary drug eluting stent market accounts for around 32% of the Asia-Pacific market in 2024
Budget 2024: Sahajanand CEO seeks strong impetus to HealthTech
Ganesh P Sabat, CEO, Sahajanand Medical Technologies Limited shares his expectations for the upcoming Budget 2024
GENESIS-II Study reveals exceptional 30-day results for the Hydra self-expanding transcatheter...
Findings presented at EuroPCR 2024 showcase the exceptional safety and efficacy of the Hydra THV, offering renewed hope for patients with severe aortic stenosis
SMT and HeartX forge transformative partnership in cardiovascular space
Through this collaboration, SMT gains an innovative product line in the Congenital Heart Defect space
India’s MedTech industry: Unleashing the next wave of growth
With COVID-19 spotlight on it, the medical devices industry is positioned to capitalize on near-term opportunities and thereby expand its horizons
The actual potential of Indian...
Made in India Supraflex stent clinically at par with Abbott’s Xience,...
The findings of the TALENT trial presented at the Transcatheter Cardiovascular Therapeutics 2018 (TCT) conference in San Diego, USA establishes India's largest stent manufacturer SMT’s Supraflex stent clinically at par with Abbott’s Xience family, with a numerically better outcome...…………..